Review article · 2022 · Open access

Countering Triple Negative Breast Cancer via Impeding Wnt/β-Catenin Signaling, a Phytotherapeutic Approach

Laleh Arzi, Homa Mollaei, Reyhane Hoshyar

Plants, 11(17), 2191 · Published 24 August 2022 · DOI 10.3390/plants11172191

Open PDFView at the publisherCite this paper

In brief

“Countering Triple Negative Breast Cancer via Impeding Wnt/β-Catenin Signaling, a Phytotherapeutic Approach” is a 2022 review article by Laleh Arzi and 2 co-authors, published in Plants. OpenAlex counts 24 citations as of 21 November 2026, which puts it in the top 4% of works published in 2022 by citations. It is open access under a CC BY licence: the full text is free to read at Plants.

Citations
24
Most cited in
2026 (8)
Field-weighted impact
0.37
References
107
Authors
3

Abstract

Triple negative breast cancer (TNBC) is characterized as a heterogeneous disease with severe malignancy and high mortality. Aberrant Wnt/β-catenin signaling is responsible for self-renewal and mammosphere generation, metastasis and resistance to apoptosis and chemotherapy in TNBC. Nonetheless, in the absence of a targeted therapy, chemotherapy is regarded as the exclusive treatment strategy for the treatment of TNBC. This review aims to provide an unprecedented overview of the plants and herbal derivatives which repress the progression of TNBC through prohibiting the Wnt/β-catenin pathway. Herbal medicine extracts and bioactive compounds (alkaloids, retinoids. flavonoids, terpenes, carotenoids and lignans) alone, in combination with each other and/or with chemotherapy agents could interrupt the various steps of Wnt/β-catenin signaling, i.e., WNT, FZD, LRP, GSK3β, Dsh, APC, β-catenin and TCF/LEF. These phytotherapy agents diminish proliferation, metastasis, breast cancer stem cell self-renewal and induce apoptosis in cell and animal models of TNBC through the down-expression of the downstream target genes of Wnt signaling. Some of the herbal derivatives simultaneously impede Wnt/β-catenin signaling and other overactive pathways in triple negative breast cancer, including: mTORC1; ER stress and SATB1 signaling. The herbal remedies and their bioactive ingredients perform essential roles in the treatment of the very fatal TNBC via repression of Wnt/β-catenin signaling.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Arzi, L., Mollaei, H., & Hoshyar, R. (2022). Countering Triple Negative Breast Cancer via Impeding Wnt/β-Catenin Signaling, a Phytotherapeutic Approach. Plants, 11(17), 2191. https://doi.org/10.3390/plants11172191

MLA 9

Arzi, Laleh, et al. “Countering Triple Negative Breast Cancer via Impeding Wnt/β-Catenin Signaling, a Phytotherapeutic Approach.” Plants, vol. 11, no. 17, 2022, p. 2191. https://doi.org/10.3390/plants11172191.

Chicago

Arzi, Laleh, Homa Mollaei, and Reyhane Hoshyar. 2022. “Countering Triple Negative Breast Cancer via Impeding Wnt/β-Catenin Signaling, a Phytotherapeutic Approach.” Plants 11 (17): 2191. https://doi.org/10.3390/plants11172191.

Harvard

Arzi, L., Mollaei, H. and Hoshyar, R. (2022) ‘Countering Triple Negative Breast Cancer via Impeding Wnt/β-Catenin Signaling, a Phytotherapeutic Approach’, Plants, 11(17), p. 2191. doi:10.3390/plants11172191.

IEEE

L. Arzi, H. Mollaei, and R. Hoshyar, “Countering Triple Negative Breast Cancer via Impeding Wnt/β-Catenin Signaling, a Phytotherapeutic Approach,” Plants, vol. 11, no. 17, p. 2191, 2022, doi: 10.3390/plants11172191.

BibTeX

@article{arzi2022countering,
  title     = {{Countering Triple Negative Breast Cancer via Impeding Wnt/β-Catenin Signaling, a Phytotherapeutic Approach}},
  author    = {Arzi, Laleh and Mollaei, Homa and Hoshyar, Reyhane},
  journal   = {Plants},
  year      = {2022},
  volume    = {11},
  number    = {17},
  pages     = {2191},
  doi       = {10.3390/plants11172191},
  url       = {https://doi.org/10.3390/plants11172191}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202366
202444
202566
202688

Its field-weighted citation impact is 0.37: it has been cited 0.37 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer

  • triple-negative breast cancer
  • Wnt/β-catenin signaling
  • herbal medicine
  • phytochemicals
  • GSK3β
  • breast cancer stem cells
  • metastasis
  • apoptosis

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Arzi, L., Mollaei, H., & Hoshyar, R. (2022). Countering Triple Negative Breast Cancer via Impeding Wnt/β-Catenin Signaling, a Phytotherapeutic Approach. Plants, 11(17), 2191. https://doi.org/10.3390/plants11172191

How many times has this paper been cited?

24 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Plants: sign in and open the PDF from this page.

Who wrote this paper?

Laleh Arzi, Homa Mollaei, Reyhane Hoshyar.

What is the DOI of this paper?

10.3390/plants11172191, permanently at https://doi.org/10.3390/plants11172191. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.